Literature DB >> 24441793

Laparoscopic approach for inflammatory bowel disease is a real alternative to open surgery: an experience with 574 consecutive patients.

Léon Maggiori1, Antoine Khayat, Xavier Treton, Yoram Bouhnik, Eric Vicaut, Yves Panis.   

Abstract

OBJECTIVE: This study aimed to report a 14-year experience of laparoscopic approach for inflammatory bowel disease (IBD), including complicated and recurrent cases.
BACKGROUND: Feasibility of laparoscopic approach for IBD surgical management has been questioned.
METHODS: From 1998 to 2012, all patients undergoing colorectal resection for IBD were prospectively enrolled. Adjusted risks of conversion and severe postoperative morbidity after laparoscopic resection were computed, according to a multivariate regression logistic model.
RESULTS: A total of 790 consecutive resections for IBD were performed on 633 patients. Laparoscopic approach was performed in 574 (73%) procedures, including 286 ileocecal resections (48%), 118 subtotal colectomies (19%), 134 ileal pouch-anal anastomoses (21%), 23 segmental colectomies (8%), and 18 abdominoperineal resections (4%). A total of 145 (25%) complex laparoscopic procedures were performed, considered as such because of iterative surgery for IBD recurrence (n = 66, 12%) or because of intra-abdominal-abscess or fistula (n = 93, 16%). Conversion to laparotomy occurred in 67 procedures (12%). Postoperative death occurred in 1 patient (0.2%). Severe postoperative morbidity occurred in 66 laparoscopic procedures (13%). Splitting the study in 5 time periods, the rate of laparoscopic procedures significantly increased from 42% in period 1 to 80% in period 5 (P < 0.001). With time, the rate of complex procedures performed laparoscopically significantly increased (P = 0.023), whereas both mean adjusted risks of conversion and severe postoperative morbidity significantly decreased (P < 0.001).
CONCLUSIONS: Laparoscopic approach is a safe and effective alternative to open surgery for IBD management. With growing experience, the rate of laparoscopic complex procedures increased, whereas adjusted risks of conversion and severe postoperative morbidity significantly decreased.

Entities:  

Mesh:

Year:  2014        PMID: 24441793     DOI: 10.1097/SLA.0000000000000534

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  5 in total

1.  Safety of supervised trainee-performed laparoscopic surgery for inflammatory bowel disease.

Authors:  Valerio Celentano; David Finch; Luke Forster; Jonathan M Robinson; John P Griffith
Journal:  Int J Colorectal Dis       Date:  2015-02-12       Impact factor: 2.571

Review 2.  Inflammatory bowel disease (IBD) position statement of the Italian Society of Colorectal Surgery (SICCR): general principles of IBD management.

Authors:  G Pellino; D S Keller; G M Sampietro; V Annese; M Carvello; V Celentano; C Coco; F Colombo; N Cracco; F Di Candido; M Franceschi; S Laureti; G Mattioli; L Pio; G Sciaudone; G Sica; V Villanacci; R Zinicola; S Leone; S Danese; A Spinelli; G Delaini; F Selvaggi
Journal:  Tech Coloproctol       Date:  2020-01-25       Impact factor: 3.781

3.  Incidence Rates and Predictors of Colectomy for Ulcerative Colitis in the Era of Biologics: Results from a Provincial Database.

Authors:  Maria Abou Khalil; Marylise Boutros; Hacene Nedjar; Nancy Morin; Gabriela Ghitulescu; Carol-Ann Vasilevsky; Philip Gordon; Elham Rahme
Journal:  J Gastrointest Surg       Date:  2017-08-14       Impact factor: 3.452

4.  Laparoscopic subtotal colectomy with double-end ileosigmoidostomy in right iliac fossa facilitates second-stage surgery in patients with inflammatory bowel disease.

Authors:  Diane Mege; Alice Frontali; Gianluca Pellino; Samuel Adegbola; Léon Maggiori; Janindra Warusavitarne; Yves Panis
Journal:  Surg Endosc       Date:  2019-03-14       Impact factor: 4.584

5.  Minimal Open Access Ileocolic Resection in Complicated Crohn's Disease of the Terminal Ileum.

Authors:  Giuseppe S Sica; Sara Di Carlo; Stefano D'Ugo; Claudio Arcudi; Leandro Siragusa; Laura Fazzolari; Livia Biancone; Giovanni Monteleone; Maurizio Cardi; Simone Sibio
Journal:  Gastroenterol Res Pract       Date:  2020-02-28       Impact factor: 2.260

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.